Zarzio(®), biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study

por Nahon, Sophie, Rastkhah, Mansour, Ben Abdelghani, Meher, Soumoudronga, Ravaka-Fatoma, Gasnereau, Isabelle, Labourey, Jean-Luc
Publicado 2015

Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer

por Bouché, Olivier, Ben Abdelghani, Meher, Labourey, Jean-Luc, Triby, Simon, Bensadoun, René-Jean, Jouary, Thomas, Des Guetz, Gaétan
Publicado 2019

Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol

por Mallard, Joris, Hucteau, Elyse, Schott, Roland, Petit, Thierry, Demarchi, Martin, Belletier, Christine, Ben Abdelghani, Meher, Carinato, Hélène, Chiappa, Pascale, Fischbach, Cathie, Kalish-Weindling, Michal, Bousinière, Audren, Dufour, Stéphane, Favret, Fabrice, Pivot, Xavier, Hureau, Thomas J., Pagano, Allan F.
Publicado 2020

A randomized phase I study comparing the pharmacokinetics of a bevacizumab (HD204) biosimilar to European Union- and United States of America-sourced bevacizumab

por Demarchi, Martin, Coliat, Pierre, Barthelemy, Philippe, Schott, Roland, BenAbdelghani, Meher, Kim, Michael, Hii, Jocelyn Chung Shii, Feyaerts, Peggy, Ang, Felicia Rui Xia, Derde, Marie Paule, Deforce, Filip, Petit, Thierry, Schwabe, Chris, Wynne, Chris, Park, Lisa Soyeon, Pivot, Xavier
Publicado 2021

MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma

por Giraud, Nicolas, Saut, Olivier, Aparicio, Thomas, Ronchin, Philippe, Bazire, Louis-Arnaud, Barbier, Emilie, Lemanski, Claire, Mirabel, Xavier, Etienne, Pierre-Luc, Lièvre, Astrid, Cacheux, Wulfran, Darut-Jouve, Ariane, De la Fouchardière, Christelle, Hocquelet, Arnaud, Trillaud, Hervé, Charleux, Thomas, Breysacher, Gilles, Argo-Leignel, Delphine, Tessier, Alexandre, Magné, Nicolas, Ben Abdelghani, Meher, Lepage, Côme, Vendrely, Véronique
Publicado 2021

Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial

por Boige, Valérie, Blons, Hélène, François, Eric, Ben Abdelghani, Meher, Phelip, Jean-Marc, Le Brun-Ly, Valerie, Mineur, Laurent, Galais, Marie Pierre, Villing, Anne-Laure, Hautefeuille, Vincent, Miglianico, Laurent, De La Fouchardière, Christelle, Genet, Dominique, Levasseur, Nadia, Levaché, Charles-Briac, Penel, Nicolas, Mitry, Emmanuel, Jacquot, Stéphane, Aparicio, Thomas, Brument, Emilie, Gourgou, Sophie, Castan, Florence, Bouché, Olivier
Publicado 2023

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study

por Gronnier, Caroline, Mariette, Christophe, Lepage, Come, Monterymard, Carole, Jary, Marine, Ferru, Aurélie, Baconnier, Mathieu, Adhoute, Xavier, Tavan, David, Perrier, Hervé, Guerin-Meyer, Véronique, Lecaille, Cédric, Bonichon-Lamichhane, Nathalie, Pillon, Didier, Cojocarasu, Oana, Egreteau, Joëlle, D’journo, Xavier Benoit, Dahan, Laétitia, Locher, Christophe, Texereau, Patrick, Collet, Denis, Michel, Pierre, Ben Abdelghani, Meher, Guimbaud, Rosine, Muller, Marie, Bouché, Olivier, Piessen, Guillaume
Publicado 2023